Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2024-22346
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
IBM i privilege escalation
Source: NVD (National Vulnerability Database)
Vulnerability Description
Db2 for IBM i 7.2, 7.3, 7.4, and 7.5 infrastructure could allow a local user to gain elevated privileges due to an unqualified library call. A malicious actor could cause user-controlled code to run with administrator privilege. IBM X-Force ID: 280203.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Source: NVD (National Vulnerability Database)
Vulnerability Type
对搜索路径元素未加控制
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM i 权限许可和访问控制问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM i是美国国际商业机器(IBM)公司的一套运行在IBM Power Systems和IBM PureSystems中的操作系统。 IBM i 7.2版本至7.5版本存在权限许可和访问控制问题漏洞,该漏洞源于基础架构可能允许本地用户因不合格的库调用而获得提升的权限,攻击者利用该漏洞可能会导致用户控制的代码以管理员权限运行。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMi 7.2, 7.3, 7.4, 7.5 -
II. Public POCs for CVE-2024-22346
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2024-22346
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2024-22346

No comments yet


Leave a comment